Revenue | ₹1.21Cr |
Net Profits | ₹0.04Cr |
Net Profit Margins | 3.31% |
Venmax Drugs & Pharmaceuticals Ltd’s revenue jumped 830.77% since last year same period to ₹1.21Cr in the Q1 2025-2026. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated -11.03% fall in its revenue since last 3-months.
Venmax Drugs & Pharmaceuticals Ltd’s net profit jumped 300% since last year same period to ₹0.04Cr in the Q1 2025-2026. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated -94.87% fall in its net profits since last 3-months.
Venmax Drugs & Pharmaceuticals Ltd’s net profit margin fell -57.02% since last year same period to 3.31% in the Q1 2025-2026. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated -94.24% fall in its net profit margins since last 3-months.
The revenue for Venmax Drugs & Pharmaceuticals Ltd in the Q1 results 2025 was ₹1.21Cr.
The net profit for Venmax Drugs & Pharmaceuticals Ltd in the Q1 results 2025 was ₹0.04Cr.
The net profit margin for Venmax Drugs & Pharmaceuticals Ltd in the Q1 results 2025 was 3.31%.
The revenue for Venmax Drugs & Pharmaceuticals Ltd in the Q1 results 2024 was ₹0.13Cr.
The net profit for Venmax Drugs & Pharmaceuticals Ltd in the Q1 results 2024 was ₹0.01Cr.
The net profit margin for Venmax Drugs & Pharmaceuticals Ltd in the Q1 results 2024 was 7.69%.